Trial intelligence / Profile preview

Nevirapine plus Lamivudine in HIV Maintenance Therapy

NCT07014189Phase 4Completed

Start
Apr 2019
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nevirapine, lamivudine in human immunodeficiency virus infection (HIV). Started Apr 2019; status: completed.

02

Drugs

nevirapinelamivudine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT07014189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07014189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call